Print

HVTN 065

A Phase I clinical trial to evaluate ?the safety and immunogenicity of pGA2/JS7 DNA Vaccine and Recombinant Modified Vaccinia Ankara/HIV62 Vaccine

Trial Details:

I Completed
Geovax, National Institute of Allergy and Infectious Diseases (NIAID), HIV Vaccine Trials Network (HVTN) April 18, 2006
pGA2/JS7 DNA,MVA/HIV62 DNA HIV-1HXB-2 Gag, HIV-1BH10 PR and RT, and Env, Tat, Rev, Vpu B; MVA gag, env, pol B
pGA2/JS7 DNA DNA
MVA/HIV62 Viral Vector - Pox
USA 120
NCT00301184
http://www.clinicaltrials.gov/ct/show/NCT00301184?order=1